As part of his fiscal year 2021 budget plan, Trump proposed ending an existing policy that protects state medical marijuana programs from Justice Department interference. This is the opposite of what he said during his first campaign.
Tag: Medical
NORML Board of Directors member Norm Kent discusses the current state of medical marijuana in the Sunshine State.
Voters this November have the opportunity to make Missouri the 32nd state to allow for the physician-recommended use of marijuana, and based on the latest polling data, they will likely do so. Therefore, the important question before voters is no longer if the Show-Me State should legalize medical cannabis access, but how Missouri will do so. Vote YES on 2.
The Oklahoma Board of Health reversed course this week and revoked their previous set of proposed rules that went against the intent of SQ 788, which voters approved in the June special election.
Proponents of a proposed 2018 medicalization initiative have gathered an estimated 160,000 signatures and appear poised to place the measure on the November ballot. Some 77 percent of Utahns either “strongly” or “somewhat” favor the plan.
Tell your federal officials to maintain this common sense protection for the 30 state medical marijuana programs and the 2,000,000 plus registered patients nationwide.
Democrat Gov. Phil Murphy signed an executive order on Tuesday calling on state regulators to review the state’s eight-year-old medical cannabis access program and to recommend ways to increase participation from patients and physicians. “Our goal is to modernize the program in New Jersey, bring it up to current standards, and put patients first,” he said.
The National Academy of Sciences, Engineering, and Medicine released a comprehensive report today acknowledging that “conclusive or substantial evidence” exists for cannabis’ efficacy in patients suffering from chronic pain, and sharply criticized longstanding federal regulatory barriers to marijuana research – in particular “the classification of cannabis as a Schedule I substance” under federal law.
